PRA discusses drivers of study success at Berlin conference
RALEIGH, N.C., Nov. 4 /PRNewswire/ -- PRA International, a leading Clinical Research Organization announces it will present during the Partnerships in Clinical Trials Congress, 4 - 7 November, 2008 in Berlin, Germany. PRA's Christian Tucat, Senior Vice President of Business Development - Europe, will present "What's next in the evolution of CRO partnerships?" at 4PM on Wednesday, 5 November. Drawing on his extensive experience, Mr. Tucat will discuss strategic options for governance and Sponsor-CRO partnering that optimizes clinical study success.
PRA provides outsourced clinical services across all phases of
pharmaceutical and biotech drug development. It conducts clinical trials in
more than 60 countries across six continents. Operating in Europe for over
27 years, PRA has executed over 1,000 studies through its 15 European
offices. PRA's capabilities in Europe include:
-- Clinical operations staff providing coverage of 38 European countries
for Phase II through Phase IV studies
-- Two 70 bed Phase I units
-- An innovative "virtual Phase I" model in central Europe
-- A world class bioanalytical laboratory
PRA will have several therapeutic and clinical experts in attendance at the Partnerships in Clinical Trials Congress, including global leaders of Oncology and Early Development Services.
About PRA International
PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Oncology, CNS, respiratory/allergy diseases, cardiovascular and infectious diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 30 global offices. PRA's therapeutic expertise, global reach, and project experience with local knowledge enable our project teams to deliver consistent and on time performance for our clients.
|SOURCE PRA International|
Copyright©2008 PR Newswire.
All rights reserved